Structures by: Shafiq M.
Total: 72
1-Ethyl-1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide
C10H11NO3S
Acta Crystallographica Section E (2008) 64, 3 o558
a=7.0272(3)Å b=8.0448(4)Å c=9.5880(4)Å
α=99.124(3)° β=95.075(3)° γ=104.092(3)°
3,3-Dibromo-1-ethyl-1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide
C10H9Br2NO3S
Acta Crystallographica Section E (2008) 64, 7 o1270
a=7.7979(5)Å b=11.9645(7)Å c=13.1231(8)Å
α=90.00° β=95.374(3)° γ=90.00°
Potassium 2-iodobenzenesulfonate monohydrate
K,C6H4IO3S,H2O
Acta Crystallographica Section E (2008) 64, 8 m994
a=13.8993(4)Å b=9.0678(3)Å c=8.1654(2)Å
α=90.00° β=92.260(2)° γ=90.00°
Methyl 2-(N-ethylmethanesulfonamido)benzoate
C11H15NO4S
Acta Crystallographica Section E (2008) 64, 2 o389-o389
a=8.0161(4)Å b=8.4386(4)Å c=10.5329(5)Å
α=85.244(3)° β=78.721(3)° γ=62.650(3)°
(Cyanomethyl)triphenylphosphonium chloride
C20H17NP,Cl
Acta Crystallographica Section E (2008) 64, 11 o2213
a=11.8269(5)Å b=11.8130(4)Å c=12.8918(5)Å
α=90° β=92.213(2)° γ=90°
Methyl 3-hydroxy-4-oxo-3,4-dihydro-2<i>H</i>-1,2-benzothiazine-3- carboxylate 1,1-dioxide monohydrate
C10H9NO6S,H2O
Acta Crystallographica Section E (2008) 64, 10 o2045
a=7.7504(5)Å b=14.5638(9)Å c=21.0615(14)Å
α=90.00° β=90.00° γ=90.00°
1-Methyl-1H-2,1-benzothiazin-4(3H)-one 2,2-dioxide
C9H9NO3S
Acta Crystallographica Section E (2008) 64, 3 o557
a=7.4553(4)Å b=8.5437(4)Å c=8.7097(4)Å
α=67.691(2)° β=70.467(2)° γ=66.327(2)°
Methyl 2-(benzenesulfonamido)acetate
C9H11NO4S
Acta Crystallographica Section E (2009) 65, 6 o1204
a=9.7268(8)Å b=5.0781(4)Å c=10.9286(9)Å
α=90.00° β=100.087(3)° γ=90.00°
2-(Prop-2-enyl)-1,2-benzisothiazol-3(2<i>H</i>)-one 1,1-dioxide
C10H9NO3S
Acta Crystallographica Section E (2009) 65, 6 o1236
a=7.2169(8)Å b=7.8347(7)Å c=10.3849(12)Å
α=105.530(3)° β=91.586(3)° γ=112.047(3)°
2-[(Methylsulfonyl)amino]benzoic acid
C8H9NO4S
Acta Crystallographica Section E (2009) 65, 10 o2453
a=5.2001(2)Å b=8.6120(4)Å c=11.2314(5)Å
α=72.675(3)° β=84.155(3)° γ=86.846(3)°
3,5-Dimethyl-2,6-diphenyl-3,4,5,6-tetrahydro-2<i>H</i>-pyran-4-one
C19H20O2
Acta Crystallographica Section E (2009) 65, 3 o463
a=14.7247(10)Å b=9.2803(7)Å c=23.0393(16)Å
α=90.00° β=90.00° γ=90.00°
4-Amino-3-bromobenzoic acid
C7H6BrNO2
Acta Crystallographica Section E (2009) 65, 3 o640
a=24.3968(11)Å b=4.8388(2)Å c=12.8040(5)Å
α=90° β=90° γ=90°
Methyl (4-bromobenzenesulfonamido)acetate
C9H10BrNO4S
Acta Crystallographica Section E (2008) 64, 12 o2380
a=6.0451(2)Å b=7.0369(2)Å c=13.8695(5)Å
α=83.866(2)° β=81.1900(10)° γ=87.027(2)°
4-Chloro-1-iodo-2-nitrobenzene
C6H3ClINO2
Acta Crystallographica Section E (2009) 65, 3 o535
a=4.1583(2)Å b=14.5213(7)Å c=13.7990(6)Å
α=90° β=93.361(2)° γ=90°
2-(4-Bromobenzenesulfonamido)benzoic acid
C13H10BrNO4S
Acta Crystallographica Section E (2009) 65, 7 o1610-o1611
a=27.8316(11)Å b=8.5684(4)Å c=11.6632(5)Å
α=90° β=98.196(2)° γ=90°
2-(4-Bromobenzenesulfonamido)-2-phenylacetic acid monohydrate
C14H12BrNO4S,H2O
Acta Crystallographica Section E (2009) 65, 8 o1953-o1954
a=5.5654(13)Å b=16.230(4)Å c=17.597(4)Å
α=90° β=90° γ=90°
Poly[hemi-μ-aqua-[μ-2-(2-bromobenzenesulfonamido)benzoato]sodium(I)]
Na,C13H9Br1N1O4S1,0.5(H2O1)
Acta Crystallographica Section E (2009) 65, 8 m982
a=9.1683(6)Å b=9.2722(5)Å c=18.4183(12)Å
α=97.717(2)° β=101.837(2)° γ=101.467(2)°
{[(4-bromophenyl)sulfonyl]amino}acetic acid
C8H8BrNO4S
Acta Crystallographica Section E (2009) 65, 8 o1816
a=5.0042(4)Å b=7.9997(6)Å c=13.2289(11)Å
α=79.691(4)° β=88.667(5)° γ=81.404(4)°
1-Propyl-1<i>H</i>-2,1-benzothiazin-4(3<i>H</i>)-one 2,2-dioxide
C11H13NO3S
Acta Crystallographica Section E (2010) 66, 11 o2839
a=7.9448(2)Å b=8.0701(3)Å c=9.6267(2)Å
α=87.468(2)° β=84.097(2)° γ=64.4530(10)°
Methyl 2-[(methylsulfonyl)(propyl)amino]benzoate
C12H17NO4S
Acta Crystallographica Section E (2010) 66, 1 o248
a=10.1762(4)Å b=15.0178(6)Å c=18.0900(8)Å
α=90° β=92.787(2)° γ=90°
Sodium 2-iodobenzenesulfonate monohydrate
Na,C6H4IO3S,H2O
Acta Crystallographica Section E (2008) 64, 12 m1628
a=13.6141(4)Å b=8.8233(3)Å c=7.8493(3)Å
α=90° β=92.1710(10)° γ=90°
6-Bromo-1-ethyl-1<i>H</i>-2,1-benzothiazin-4(3<i>H</i>)-one 2,2-dioxide
C10H10BrNO3S
Acta Crystallographica Section E (2009) 65, 2 o393
a=7.7164(2)Å b=7.9729(3)Å c=10.4579(3)Å
α=86.767(2)° β=75.7730(10)° γ=66.912(2)°
4-(2-Iodobenzenesulfonamido)benzoic acid monohydrate
C13H10INO4S,H2O
Acta Crystallographica Section E (2009) 65, 2 o230
a=13.8049(9)Å b=8.2756(5)Å c=14.7928(10)Å
α=90° β=117.472(3)° γ=90°
3,3-Dichloro-1-ethyl-1<i>H</i>-2,1-benzothiazin-4(3<i>H</i>)-one 2,2-dioxide
C10H9Cl2NO3S
Acta Crystallographica Section E (2009) 65, 2 o430
a=7.7416(2)Å b=11.9185(3)Å c=12.9614(3)Å
α=90° β=95.995(2)° γ=90°
2-Chloro-5-(2-iodobenzenesulfonamido)benzoic acid
C13H9ClINO4S
Acta Crystallographica Section E (2009) 65, 2 o281
a=26.6375(9)Å b=8.5532(2)Å c=14.2696(5)Å
α=90° β=111.923(2)° γ=90°
2-Bromo-4-nitroaniline
C6H5BrN2O2
Acta Crystallographica Section E (2009) 65, 3 o480
a=11.098(3)Å b=16.763(4)Å c=3.9540(9)Å
α=90° β=90° γ=90°
2-(2-Iodobenzenesulfonamido)acetic acid
C8H8INO4S
Acta Crystallographica Section E (2009) 65, 3 o549
a=5.5877(2)Å b=8.0145(2)Å c=12.3584(4)Å
α=80.923(2)° β=83.398(2)° γ=88.038(2)°
5-Benzenesulfonamido-2-chlorobenzoic acid
C13H10ClNO4S
Acta Crystallographica Section E (2009) 65, 4 o831
a=11.7139(4)Å b=5.3957(2)Å c=20.7565(8)Å
α=90° β=91.483(2)° γ=90°
6-Bromo-1-methyl-1<i>H</i>-2,1-benzothiazin-4(3<i>H</i>)-one 2,2-dioxide
C9H8BrNO3S
Acta Crystallographica Section E (2009) 65, 5 o1182
a=5.4577(3)Å b=12.6400(8)Å c=15.1258(10)Å
α=90.00° β=96.204(2)° γ=90.00°
(2<i>R</i>)-2-Benzenesulfonamido-2-phenylethanoic acid
C14H13NO4S
Acta Crystallographica Section E (2009) 65, 5 o940
a=5.6022(5)Å b=12.5026(9)Å c=19.7886(15)Å
α=90° β=90° γ=90°
Methyl 5-bromo-2-[methyl(methylsulfonyl)amino]benzoate
C10H12BrNO4S
Acta Crystallographica Section E (2009) 65, 5 o955
a=6.07980(10)Å b=10.7853(3)Å c=19.5206(4)Å
α=90° β=90.3060(10)° γ=90°
4-{[(4-Bromophenyl)sulfonyl]amino}benzoic acid
C13H10BrNO4S
Acta Crystallographica Section E (2009) 65, 5 o1073
a=5.1344(5)Å b=13.1713(11)Å c=20.0224(19)Å
α=90.00° β=91.730(5)° γ=90.00°
6-Bromo-3,3-dichloro-1-methyl-1<i>H</i>-2,1-benzothiazin-4(3<i>H</i>)-one 2,2-dioxide
C9H6BrCl2NO3S
Acta Crystallographica Section E (2009) 65, 6 o1413
a=7.0285(9)Å b=14.865(2)Å c=11.9739(18)Å
α=90° β=92.418(5)° γ=90°
2-(Methoxycarbonyl)anilinium dihydrogen phosphate
C8H10NO2,H2O4P
Acta Crystallographica Section E (2009) 65, 8 o1786
a=20.939(3)Å b=4.7880(5)Å c=22.283(4)Å
α=90.00° β=114.970(5)° γ=90.00°
Methyl 2-[methyl(methylsulfonyl)amino]benzoate
C10H13NO4S
Acta Crystallographica Section E (2009) 65, 10 o2588
a=8.7476(4)Å b=10.2081(4)Å c=13.8377(7)Å
α=90.00° β=108.347(3)° γ=90.00°
<i>N</i>-Cyclohexyl-<i>N</i>-methylbenzenesulfonamide
C13H19NO2S
Acta Crystallographica Section E (2009) 65, 11 o2892
a=9.2729(5)Å b=12.1182(7)Å c=12.5801(7)Å
α=90.00° β=109.103(2)° γ=90.00°
<i>N</i>-Cyclohexyl-<i>N</i>-ethylbenzenesulfonamide
C14H21NO2S
Acta Crystallographica Section E (2009) 65, 11 o2867
a=18.1950(10)Å b=12.9799(7)Å c=12.7327(6)Å
α=90.00° β=108.587(3)° γ=90.00°
4-Hydroxy-<i>N</i>-(2,4,6-tribromophenyl)-2<i>H</i>-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C15H9Br3N2O4S
Acta Crystallographica Section E (2009) 65, 12 o2998
a=7.5082(4)Å b=8.7486(6)Å c=13.0669(9)Å
α=83.618(2)° β=86.280(2)° γ=87.684(2)°
<i>N</i>-Cyclohexyl-<i>N</i>-(prop-2-en-1-yl)benzenesulfonamide
C15H21NO2S
Acta Crystallographica Section E (2009) 65, 12 o3102
a=8.4911(5)Å b=11.4176(6)Å c=15.6274(10)Å
α=90.00° β=94.188(3)° γ=90.00°
<i>N</i>-Benzyl-<i>N</i>-cyclohexyl-4-methylbenzenesulfonamide
C20H25NO2S
Acta Crystallographica Section E (2009) 65, 12 o3109
a=9.0702(4)Å b=11.1054(5)Å c=18.1971(8)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-cyclohexyl-<i>N</i>-ethylbenzenesulfonamide
C14H21NO2S
Acta Crystallographica Section E (2009) 65, 12 o3107
a=8.3837(4)Å b=11.4467(5)Å c=15.1488(7)Å
α=90.00° β=92.541(2)° γ=90.00°
<i>N</i>-(Phenylsulfonyl)-L-asparagine
C10H12N2O5S
Acta Crystallographica Section E (2009) 65, 12 o3229
a=10.5479(6)Å b=5.1587(3)Å c=11.0157(7)Å
α=90.00° β=92.011(3)° γ=90.00°
<i>N</i>-Cyclohexyl-<i>N</i>-ethyl-4-methylbenzenesulfonamide
C15H23NO2S
Acta Crystallographica Section E (2010) 66, 1 o102
a=12.2269(5)Å b=7.5818(3)Å c=16.3045(6)Å
α=90.00° β=92.495(2)° γ=90.00°
<i>N</i>-(<i>p</i>-Tolylsulfonyl)-L-asparagine
C11H14N2O5S
Acta Crystallographica Section E (2010) 66, 3 o541
a=8.7566(6)Å b=22.900(2)Å c=6.9692(7)Å
α=90.00° β=90.00° γ=90.00°
3,3,6-Tribromo-1-methyl-1<i>H</i>-2,1-benzothiazin-4(3<i>H</i>)-one 2,2-dioxide
C9H6Br3NO3S
Acta Crystallographica Section E (2010) 66, 12 o3109
a=14.9220(10)Å b=12.1310(8)Å c=7.0811(4)Å
α=90.00° β=90.00° γ=90.00°
3-[4-(Acetamido)benzenesulfonamido]benzoic acid
C15H14N2O5S
Acta Crystallographica Section E (2011) 67, 1 o25-o26
a=7.9829(3)Å b=8.4143(3)Å c=12.6554(5)Å
α=70.888(2)° β=81.553(2)° γ=77.104(2)°
6-Bromo-4-hydrazinylidene-1-methyl-3<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C9H10BrN3O2S
Acta Crystallographica Section E (2011) 67, 8 o2078
a=10.1483(5)Å b=9.6375(4)Å c=11.2118(5)Å
α=90.00° β=92.278(2)° γ=90.00°
Methyl 2-benzyl-4-hydroxy-1,1-dioxo-1,2,3,4-tetrahydro-1λ^6^,2-benzothiazine-3-carboxylate
C17H15NO5S
Acta Crystallographica Section E (2011) 67, 7 o1588-o1589
a=9.4920(15)Å b=10.9607(17)Å c=15.050(2)Å
α=90.00° β=99.758(2)° γ=90.00°
4-Hydrazinylidene-1-methyl-3<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C9H11N3O2S
Acta Crystallographica Section E (2011) 67, 8 o2038
a=6.6643(2)Å b=9.6834(3)Å c=15.5890(5)Å
α=90.00° β=97.6990(10)° γ=90.00°
(3<i>S</i>,4<i>Z</i>)-3-Chloro-1-methyl-4-[(2<i>E</i>)-(3- methylbenzylidene)hydrazinylidene]-3,4-dihydro-1<i>H</i>-2,1-benzothiazine 2,2-dioxide
C17H16ClN3O2S
Acta Crystallographica Section E (2012) 68, 2 o338
a=8.7734(2)Å b=11.1271(2)Å c=17.9423(3)Å
α=90° β=90° γ=90°
1-(Benzotriazol-1-yl)-2-bromoethanone
C8H6BrN3O
Acta Crystallographica Section E (2012) 68, 11 o3179
a=12.4815(4)Å b=4.72070(10)Å c=15.4780(5)Å
α=90.00° β=103.468(3)° γ=90.00°
6-Bromo-1-methyl-4-[2-(4-nitrobenzylidene)hydrazin-1-ylidene]-2,2-dioxo-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine
C16H13BrN4O4S
Acta Crystallographica Section E (2012) 68, 9 o2717
a=8.2772(4)Å b=9.0572(4)Å c=12.6868(6)Å
α=87.132(4)° β=70.976(3)° γ=75.098(2)°
6-Bromo-4-(2-cyclohexylidenehydrazin-1-ylidene)-1-methyl-2,2-dioxo-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine
C15H18BrN3O2S
Acta Crystallographica Section E (2012) 68, 7 o2088-o2089
a=9.9357(2)Å b=11.2614(3)Å c=15.8263(3)Å
α=110.6250(10)° β=91.525(3)° γ=102.879(4)°
1-Methyl-4-[1-(1-phenylethylidene)-hydrazin-2-ylidene]-3,4-dihydro-1<i>H</i>- 2λ^6^,1-benzothiazine-2,2-dione
C17H17N3O2S
Acta Crystallographica Section E (2012) 68, 7 o2100
a=6.6678(2)Å b=12.0783(6)Å c=20.0529(8)Å
α=90.00° β=90.00° γ=90.00°
Ethyl (<i>Z</i>)-2-chloro-2-[2-(4-methoxyphenyl)hydrazin-1-ylidene]acetate
C11H13ClN2O3
Acta Crystallographica Section E (2012) 68, 12 o3274
a=4.7480(2)Å b=9.9256(4)Å c=13.3084(4)Å
α=90.00° β=91.468(3)° γ=90.00°
1-[(1<i>Z</i>)-1-Ferrocenylethylidene]thiocarbonohydrazide
C13H16FeN4S
Acta Crystallographica Section E (2012) 68, 12 m1439
a=6.4560(2)Å b=13.0664(3)Å c=15.8559(4)Å
α=90.00° β=91.028(2)° γ=90.00°
2-{(<i>E</i>)-[(2<i>Z</i>)-(3-Chloro-1-methyl-2,2-dioxo-3,4-dihydro- 1<i>H</i>-2,1-benzothiazin-4-ylidene)hydrazinylidene]methyl}phenol
C16H14ClN3O3S
Acta Crystallographica Section E (2012) 68, 2 o307
a=7.0973(5)Å b=12.0957(7)Å c=18.7396(13)Å
α=90.00° β=96.058(4)° γ=90.00°
3-Chloro-1-methyl-4-[2-(3-phenylallylidene)hydrazinylidene]-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C18H16ClN3O2S
Acta Crystallographica Section E (2013) 69, 2 o165
a=7.2262(5)Å b=13.5823(9)Å c=17.9818(12)Å
α=90.00° β=97.023(4)° γ=90.00°
2-Chloro-4-(2-iodobenzenesulfonamido)benzoic acid
C13H9ClINO4S
Acta Crystallographica Section E (2011) 67, 6 o1327
a=14.1522(8)Å b=7.3203(4)Å c=14.7193(8)Å
α=90.00° β=104.892(2)° γ=90.00°
6-Bromo-1-methyl-4-[2-(4-methylbenzylidene)hydrazinylidene]-3<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C17H16BrN3O2S
Acta Crystallographica Section E (2011) 67, 8 o2092
a=9.1077(6)Å b=6.8328(4)Å c=14.1765(9)Å
α=90.00° β=96.807(3)° γ=90.00°
<i>N</i>-[4-(4-Methylbenzenesulfonamido)phenylsulfonyl]acetamide
C15H16N2O5S2
Acta Crystallographica Section E (2012) 68, 4 o983-o984
a=9.6722(3)Å b=11.9968(4)Å c=15.4784(6)Å
α=82.802(2)° β=79.2320(10)° γ=89.653(2)°
1-Ethyl-4-[1-(1-phenylethylidene)hydrazin-2-ylidene]-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C18H19N3O2S
Acta Crystallographica Section E (2012) 68, 6 o1927
a=9.7278(3)Å b=12.4327(3)Å c=14.2607(4)Å
α=90.00° β=100.7250(10)° γ=90.00°
<i>rac</i>-(3<i>S</i>,4<i>Z</i>)-3-Chloro-4-[2-(3- fluorobenzylidene)hydrazinylidene]- 3-chloro-1-methyl-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C16H13ClFN3O2S
Acta Crystallographica Section E (2012) 68, 6 o1787
a=7.0072(3)Å b=8.9402(4)Å c=13.3438(6)Å
α=98.184(3)° β=90.510(2)° γ=98.389(3)°
4-[2-(Anthracen-9-ylmethylidene)hydrazinylidene]-3-chloro-1-methyl- 3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C24H18ClN3O2S
Acta Crystallographica Section E (2012) 68, 6 o1788
a=8.5133(4)Å b=19.8999(8)Å c=12.7849(6)Å
α=90° β=105.026(2)° γ=90°
2-{[2-(1-Methyl-2,2-dioxo-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazin-4-ylidene)hydrazin-1-ylidene]methyl}phenol
C16H15N3O3S
Acta Crystallographica Section E (2012) 68, 9 o2643
a=6.5530(2)Å b=15.8719(5)Å c=14.5804(4)Å
α=90.00° β=91.1470(10)° γ=90.00°
4-Bromo-2-{(<i>E</i>)-[(3,4-dimethylphenyl)imino]methyl}phenol
C15H14BrNO
Acta Crystallographica Section E (2012) 68, 9 o2730
a=12.2633(10)Å b=7.4805(6)Å c=14.5767(11)Å
α=90° β=101.576(4)° γ=90°
1-(1<i>H</i>-1,2,3-Benzotriazol-1-yl)-2-(4-methoxyphenyl)ethanone
C15H13N3O2
Acta Crystallographica Section E (2012) 68, 11 o3221
a=5.42090(10)Å b=24.4894(5)Å c=10.0555(2)Å
α=90.00° β=98.552(2)° γ=90.00°
6-Bromo-4-[2-(4-fluorobenzylidene)hydrazin-1-ylidene]-1-methyl-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C16H13BrFN3O2S
Acta Crystallographica Section E (2012) 68, 10 o2851
a=7.8996(4)Å b=9.0070(4)Å c=13.5057(7)Å
α=104.176(3)° β=90.977(3)° γ=113.466(3)°
(4<i>Z</i>)-1-Methyl-4-[(2<i>E</i>)-2-(4-methylbenzylidene)hydrazin-1- ylidene]-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C17H17N3O2S
Acta Crystallographica Section E (2012) 68, 10 o2971
a=7.8990(10)Å b=25.061(3)Å c=8.1743(11)Å
α=90.00° β=101.114(9)° γ=90.00°
1-Ethyl-4-{2-[1-(4-methylphenyl)ethylidene]hydrazinylidene}-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C19H21N3O2S
Acta Crystallographica Section E (2013) 69, 2 o200
a=15.9018(10)Å b=7.3716(4)Å c=16.8376(10)Å
α=90.00° β=111.644(3)° γ=90.00°
6-Bromo-1-methyl-4-[2-(1-phenylethylidene)hydrazinylidene]- 3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C17H16BrN3O2S
Acta Crystallographica Section E (2013) 69, 2 o164
a=16.4369(13)Å b=6.5400(5)Å c=16.5025(17)Å
α=90.00° β=104.312(4)° γ=90.00°
3-Chloro-4-[2-(4-chlorobenzylidene)hydrazinylidene]-1-methyl-3,4-dihydro-1<i>H</i>-2λ^6^,1-benzothiazine-2,2-dione
C16H13Cl2N3O2S
Acta Crystallographica Section E (2013) 69, 3 o422-o423
a=12.309(2)Å b=17.189(3)Å c=8.1837(13)Å
α=90.00° β=101.632(8)° γ=90.00°